| |
CON n=19
|
MDD n=13
|
BPD n=13
|
DD (combined) n=23
|
|---|
|
Age (years)
|
46.6±2.9
|
44.6±3.3
|
48.1±4.6
|
46.1±2.7
|
|
HRSD
| |
36.6±3.7
|
33.8±3.0
|
35.4±2.4
|
|
QIDSA
|
3.32±0.6
|
19.67±1.5
|
19.38±1.3
|
19.55±1.0
|
|
No medication
|
17
|
0
|
0
|
0
|
|
AntidepressantsB
|
0
|
13
|
6
|
19
|
|
Anticonvulsants (N/S/C)C
|
(17/0/2)
|
(3/2/8)
|
(3/1/6)
|
(6/3/14)
|
|
Antipsychotic
|
0
|
5
|
6
|
11
|
-
AQIDS was significantly higher in MDD (p <0.001), BPD (p <0.001), and DD (p <0.001) relative to CON.
-
BAntidepressant use has higher in MDD vs. BPD χ2 4.749 (p =0.01) and vs. CON (p <0.01).
-
CAnticonvulsant (N = not on, S = stopped in anticipation of ECT, C = currently on).
